• Meeting challenges with practical solutions from world-class experts

  • Tackle the new realities of drug development and commercialization with Quintiles’ broad industry expertise. The result: Strategies that drive success.

    • Build value across the clinical and commercial lifecycle
    • Improve processes and productivity
    • Reduce infrastructure costs while optimizing portfolio value
    • Provide stakeholders with the right evidence - from the start
    • Proactively manage quality and regulatory compliance
    • Gain insight that helps you make the best decisions ­- the first time

  • Our Perspectives

    slider image

    Strategic Portfolio Management

    How can good portfolio planning help to ensure commercial success of a product? Read white paper

    slider image

    The Art of Compliance

    Turning regulatory compliance into sustainable business advantage. Read white paper

    slider image

    Oncology Drug Development and Value-Based Medicine

    The growing voice of stakeholders, from patients to payers, is changing the path of drug development. Read white paper

  •  
     

    Video Spotlights 

  • Insight and strategy seamlessly translating to execution

    Quintiles
    With access to all Quintiles’ experts, our integrated consulting teams bring you implementatble, sustainable solutions across the lifecycle.

    A seismic power shift from providers to payers makes proving value an ongoing challenge. Learn more

    Heightened regulatory scrutiny can turn compliance into a competitive edge. Find out how

    As market pressures mount, process efficiencies can make the difference between success and failure. Read more

  • Featured News

    Quintiles Announces Completion of Initial Public Offering of 27,236,841 Shares of Common Stock
    Read more

    Quintiles Announces Pricing of Initial Public Offering
    Read more

    Quintiles Unlocks Path for Digital Patient Engagement
    Read more

    Our Perspectives

    Harnessing the Power of the Digital Patient White Paper
    Read more

    Tomorrow’s Path to Improved Early-Phase Oncology Drug Development
    Read more

    Strategic Portfolio Management & New Influencers in R&D Decision-Making
    Read more